A phase 2 study of K-134 in patients with peripheral arterial disease.
Phase of Trial: Phase II
Latest Information Update: 20 May 2016
At a glance
- Drugs K 134 (Primary)
- Indications Embolism and thrombosis; Intermittent claudication; Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa Pharmaceutical
- 21 Nov 2014 New source identified and integrated (JAPIC Clinical Trials Information; JapicCTI-090869).
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 16 Nov 2011 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History